Comparative Pharmacology
Head-to-head clinical analysis: TYCOLET versus TYLOX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TYCOLET versus TYLOX.
TYCOLET vs TYLOX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen: COX-1/COX-2 inhibitor in CNS; Paracetamol: analgesic and antipyretic via central inhibition of prostaglandin synthesis.
Tylox combines oxycodone, a mu-opioid receptor agonist, with acetaminophen, which inhibits cyclooxygenase (COX) and modulates descending serotonergic pathways.
500-1000 mg orally or intravenously every 4-6 hours, maximum 4 g/day.
1-2 capsules (oxycodone 5 mg/acetaminophen 325 mg) orally every 6 hours as needed for pain; maximum 12 capsules per day.
None Documented
None Documented
Terminal elimination half-life is 2-4 hours; prolonged in renal impairment (up to 12-24 hours in ESRD).
Oxycodone: 3.5-5.6 hours; acetaminophen: 2-3 hours. In hepatic impairment, oxycodone half-life prolonged up to 13 hours.
Renal: 70-80% unchanged; Biliary/fecal: 10-15% as metabolites.
Renal: oxycodone ~19% unchanged; acetaminophen ~2-5% unchanged. Biliary: minimal. Fecal: <5% total. Total renal elimination: ~60-70% as metabolites of oxycodone (noroxycodone, oxymorphone) and acetaminophen conjugates.
Category C
Category C
Opioid analgesic combination
Opioid analgesic combination